Results 241 to 250 of about 5,054,451 (380)

The Effect of Carnitine on the Metabolism of Valproic Acid in Epileptic Patients.

open access: bronze, 1992
Kikuo Sakemi   +4 more
openalex   +2 more sources

Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract The peripheral T‐cell lymphomas (PTCL) are the only disease for which four histone deacetylase (HDAC) inhibitors have been approved globally as single agents. Although it is not clear why the PTCL exhibit such a vulnerability to these drugs, understanding the biological basis for this activity is essential.
Ariana Sabzevari   +7 more
wiley   +1 more source

Clinical studies on serum concentration of free fraction of phenytoin, carbamazepine and valproic acid.

open access: bronze, 1990
Jun Hosoya   +5 more
openalex   +2 more sources

Access to Highly Functional and Polymerizable Carbonate‐Drug Conjugates

open access: yesChemSusChem, Volume 18, Issue 11, June 2, 2025.
A generic protocol for drug‐functionalized and carbon dioxide‐based six‐membered cyclic carbonates has been developed. These functional carbonates can be designed for effective ring‐opening polymerization to forge polycarbonates that support a controllable amount of a given drug and additional functionality, opening up complementary strategies for ...
Wangyu Shi   +5 more
wiley   +1 more source

Enhancing transporter activity in heterologous expression systems with SAHA: a 2500‐times more potent and odorless alternative to butyrate

open access: yesFEBS Open Bio, Volume 15, Issue 6, Page 906-913, June 2025.
Heterologous expression of membrane transporters in cultured cells is essential for functional characterization, but is sometimes limited by low activity. Our study compares the HDAC inhibitors butyrate, VPA and SAHA to enhance transport activity. We propose to replace butyrate by SAHA: it is equally effective, devoid of repulsive odor, costs less, and
Svenja Flögel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy